Company / Operating Cash Flow
BioCardia, Inc. Operating Cash Flow History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$8.7M
FY2017
5-year range
-$8.7M / -$3.1M
FY2013-FY2017
Trend
-57.0%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$3M to -$9M over the past 6 years.
Based on SEC 10-K filings.
-$9M in FY2017.
Declined from -$3M to -$9M over the past 6 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, operating cash flow decreased 57.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$8.7M | -57.0% |
| FY2016 | -$5.5M | -78.9% |
| FY2011 | -$3.1M | - |
As of FY2017 · SEC Form 10-K · Last checked Jun 21, 2026